Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

ClinicalTrials.gov ID: NCT04458831

Public ClinicalTrials.gov record NCT04458831. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT04458831
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Sanofi
Industry
Enrollment
583 participants

Conditions and interventions

Interventions

  • isatuximab SAR650984 Drug
  • Pomalidomide Drug
  • Dexamethasone Drug
  • Carfilzomib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 12, 2020
Primary completion
Feb 22, 2026
Completion
Feb 22, 2026
Last update posted
Jun 26, 2025

2020 – 2026

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
24
Facility City State ZIP Site status
University of Arkansas Medical Sciences Site Number : 8400021 Little Rock Arkansas 72205-7199
St. Joseph Heritage Healthcare Site Number : 8400008 Fullerton California 92835
University of California San Francisco (PARENT) Site Number : 8400009 San Francisco California 94143
Holy Cross Hospital Site Number : 8400030 Fort Lauderdale Florida 33308
GenesisCare Site Number : 8400007 Jacksonville Florida 32204
Watson Clinic Cancer and Research Center Site Number : 8400023 Lakeland Florida 33805
Millennium Oncology Site Number : 8400025 Pembroke Pines Florida 33024
Comprehensive Hematology Oncology Site Number : 8400026 St. Petersburg Florida 33709
Central Care Cancer Center Site Number : 8400019 Garden City Kansas 67846
Central Maine Medical Center Site Number : 8400031 Lewiston Maine 04240
Michigan Center of Medical Research Site Number : 8400010 Farmington Hills Michigan 48334
Central Care Cancer Center Site Number : 8400006 Garden City Missouri 67846
AMR Kansas City Site Number : 8400016 Kansas City Missouri 64114
Regional Cancer Care Associates, LLC - Freehold Division Site Number : 8400017 Freehold New Jersey 07728
Regional Cancer Care Associates Site Number : 8400024 Howell Township New Jersey 07731
Regional Cancer Care Associates - Little Silver Division Site Number : 8400018 Little Silver New Jersey 07739
Novant Health Forsyth Medical Center Site Number : 8400028 Winston-Salem North Carolina 27103
Hematology & Oncology Associates Site Number : 8400015 Canton Ohio 44708
Tri County Hematology & Oncology Associates, Inc Site Number : 8400012 Massillon Ohio 44646
Charleston Hematology Oncology Associates, PA Site Number : 8400020 Charleston South Carolina 29414
Prisma Health - Eastside Office Site Number : 8400011 Greenville South Carolina 29615
Prairie Lakes Health Care System, Inc Site Number : 8400002 Watertown South Dakota 57201-1548
MD Anderson Cancer Center Site Number : 8400013 Houston Texas 77030-4000
Renovatio Clinical Site Number : 8400004 The Woodlands Texas 77380

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 105 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04458831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04458831 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →